The weekly litigation news digest is live. Subscribe now

IP Verse

Ventana Medical Systems competitive analysis

Loading summary...

Latest patents of Ventana Medical Systems opposed by its competitors

Explore Ventana Medical Systems's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3111221
Jan 19, 2022Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp31
EP3149481
Jan 9, 2019Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L11
EP2898329
May 17, 2017Method Of Identifying Treatment Responsive Non-Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (Alk) As A Marker1

Latest PTAB cases involving Ventana Medical Systems

Discover the latest PTAB cases involving Ventana Medical Systems, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ventana Medical Systems with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
VENTANA MEDICAL SYSTEMS - 3 - -
CMS CAMERON MCKENNA NABARRO OLSWANG11 - - -
HOFFMANN EITLE148 - - -